Autoimmune disease and aesthetic medicine: a holistic approach
DOI:
https://doi.org/10.12775/QS.2024.18.53918Keywords
aesthetic procedures, autoimmune diseases, side-effects of asthetic proceduresAbstract
Introduction and purpose
The field of aesthetic medicine has experienced rapid advancement in recent years. It serves primarily aesthetic purposes while also supporting various medical treatments. The range of available aesthetic medicine procedures continues to expand, with numerous studies confirming their therapeutic efficacy in treating certain diseases or conditions. Conversely, a substantial list of contraindications exists, particularly in autoimmune diseases, necessitating caution and precluding the performance of certain aesthetic treatments.
Autoimmune diseases entail the body's immune system attacking its tissues, a process whose complete development and maintenance in specific diseases remains incompletely understood. Injection treatments like hyaluronic acid and mesotherapy have demonstrated considerable promise in aiding individuals with autoimmune connective tissue diseases to lead everyday lives.
This study discusses to what extent selective aesthetic medical procedures could be safely performed in patients with the most common autoimmune diseases.
Material and methods
A literature review was conducted through an extensive bibliographic search, primarily focusing on original research articles from reputable databases such as PubMed, BioMed Central, Polish Medical Platform, and Google Scholar. The search was specifically targeted towards articles discussing particular autoimmune diseases and specific aesthetic procedures.
Conclusion
Established relationships between autoimmune diseases and specific aesthetic medicine treatments have been identified, highlighting their ineffectiveness or inadvisability. In such instances, the physician's extensive knowledge and the necessity for a comprehensive, individually tailored assessment before the procedure often dictate a patient's exclusion from specific therapies.
References
Deptuła W. et al.: Immunology - known and unknown facts , Wydawnictwo PWSZ im. Witelon in Legnica, Legnica 2014; J. Gołąb et al., op. cit.
Deptuła W. et al., op. cit.; J. Gołąb et al., op. cit.; A. Mękal et al.: Age and immune system cells. "Giatria" 2011, no. 5.
Dymarska E.: Factors modulating the human immune system - ISSN 1896-8333, - No. 19 (2) / 2016.
Gołąb J.; Jakubisiak M.; Lasek W.: Immunologia , PWN Scientific Publishing House, Warsaw 2006.
Bart O. Roep, Sofia Thomaidou, René van Tienhoven, Arnaud Zaldumbide. Type 1 diabetes mellitus as a disease of the β-cell (do not blame the immune system?). Nat Rev Endocrinol. 2021; 17(3): 150–161.
Wakefield RJ; Balint PV; Szkudlarek M. et al.: OMERACT 7 Special Interest Group. Musculoskeletal ultrasound including definitions for ultrasonographic pathology . J Rheumatol. 2005; 32(12): 2485–2487.
Firestein GS; Gabriel SE; McInnes IB; O'Dell JR: Kelley and Firestein's Textbook of Rheumatology. 10th ed. Philadelphia, PA: Elsevier; 2017.
Hay EM: Systemic lupus erythematosus. Bailliere's Clinical Rheumatology. 1995; 9: 437–470.
Mosca M.; Tani C.; Aringer M; Bombardieri S.; Boumpas D.; Brey R. et al.: EULAR Recommendations for monitoring systemic lupus erythematosus patients in clinical practice and in observational studies Ann. Rhem. Dis. 2010; 69: 1269–1274.
Zimmermann MB; Boelaert K.: Iodine deficiency and thyroid disorders . April 1, 2015; Medicine, Environmental Science.
Tomer Y.; Mechanisms of autoimmune thyroid diseases: from genetics to epigenetics . Annu Rev Pathol.
Smith, T.J.; Hegedüs L.: Graves' Disease. The New England Journal of Medicine, 2016.
Gołkowski, F.: Current perspective on the etiopathogenesis and clinical aspects of Hashimoto's disease .01/2016.
Pound, D.; Pavicic, T.: Dermal fillers in aesthetics: An overview of adverse events and treatment approaches . Clin. Cosmet. Investig. Dermatol. 2013, 6, 295–316.
Gualdi G.; Monari P.; Cammalleri D.; Pelizzari L.; Calzavara-Pinton P.: Hyaluronic acid-based products are strictly contraindicated in scleroderma-related skin ulcers. Wounds. 2019;31(3):81-84.
Owczarczyk-Saczeniek A.; Zdanowska N.; Wygonowska E.; Placek W.: The immunogenicity of hyaluronic fillers and its consequences. Clin Cosmet Investig Dermatol. 2021; 14:921-934.
Bhatia KP; Münchau A.; Brown P.: Botulinum toxin is a useful treatment in extensive drooling of saliva. J Neurol Neurosurg Psychiatry. 1999; 67:697 –9.
Edvina Gregoric, Jurji Avramovic Gregoric, Fabrizio Guarneri, Salvatore Benvenga. Injections of Clostridium botulinum neurotoxin A may cause thyroid complications in predisposed persons based on molecular mimicry with thyroid autoantigens. Endocrine. 2011 Feb;39(1):41-7.doi: 10.1007/s12020-010-9410-9.
Dressler D.; Saberi A.: Antibody-Induced Failure of Botulinum Toxin Type B Therapy in de novo Patients . J Neurol Neurosurg Psychiatry. 2007; 78:108 –9.
Naumann M; Zellner M.; Toyka KV; Reiners K.: Treatment of gustatory sweating with botulinum toxin. Ann Neurol. 1997; 42:973 –5.
Feigin K.; Shope, B.: Use of Platelet-Rich Plasma and Platelet-Rich Fibrin in Dentistry and Oral Surgery: Introduction and Review of the Literature . J. Vet. Dent. 2019, 36, 109–123.
Borhani-Haghighi, M.; Mohamadi, Y.: The therapeutic effect of platelet-rich plasma on the experimental autoimmune encephalomyelitis mice. J. Neuroimmunol. 2019, 333, 476958.
Kim, J. H.; Park, J. H.; Kim, S. Y.; Bae, HY: The mean platelet volume is positively correlated with serum thyrotropin concentrations in a population of healthy subjects and subjects with unsuspected subclinical hypothyroidism. Thyroid 2013, 23, 31–37.
Lee YI; Lee E.; Nam K.-H.; Shin DY; Kim J; Suk J; Kwak JY; Lee, J. H.: The Use of a Light-Emitting Diode Device for Neck Rejuvenation and Its Safety on Thyroid Glands . J. Clin. Med. 2021, 10, 1774.
Halachmi S.; Gabari O.; Cohen S.; Koren R.; Amitai D.B.; Lapidoth M.: Telangiectasis in CREST syndrome and systemic sclerosis: correlation of clinical and pathological features with response to pulsed dye laser treatment. Lasers Med Sci. 2014; 29:137-140.
Shalaby SM; Bosseil M.; Fawzy MM; Abdel Halim DM; Sayed SS; Allam RS: Fractional carbon dioxide laser versus low-dose UVA-1 phototherapy for treatment of localized scleroderma: a clinical and immunohistochemical randomized controlled study. Lasers Med Sci. 2016; 31:1707-1715.
Chamberlain A.J.; Walker NP: Successful palliation and significant reduction of cutaneous calcinosis in CREST syndrome with carbon dioxide laser. Dermatol Surg. 2003; 29:968-970.
Markiewicz A.; Principle M; Erkiert-Polguj A.; Wieckowska-Szakiel M.; Budzisz, E.: An evaluation of the antiaging properties of strawberry hydrolysate treatment enriched with L-ascorbic acid applied with microneedle mesotherapy. J.Cosmet. Dermatol. 2019, 18, 129–135.
Chandrashekar BS: Triamcinolone Acetonide Mesotherapy in the Treatment of Recalcitrant Patches of Alopecia Areata—A Pilot Study. Clin. Dermatology Ther. 2015, 2, 1–4.
Onesti MG; Monarch C.; Rizzo MI; Mazzocchi M; Scuderi N.: Minimally invasive combined treatment for Parry-Romberg syndrome. Aesthetic Plast Surg. 2009; 33:452-456.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Magdalena Górska, Bożena Kmak, Anna Szot
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 1756
Number of citations: 0
